Skip to main content
. 2020 Sep;18(5):413–421. doi: 10.1370/afm.2562

Table 1.

Changes to Health Canada Regulations for Mifepristone-Misoprostol Medical Abortion, as of January 2020

Topic Change Date Changed
Observed ingestion Removed requirement for observation of mifepristone ingestion. The patient can take the drug where and when they choose. October 2016
Training Removed requirement for training for pharmacists. May 2017
Training Removed requirement for training for prescribers. November 2017
Consent form Removed requirement for a manufacturer consent form to be signed by the patient. November 2017
Registration Removed requirement for registration of prescribers or pharmacists with the manufacturer. November 2017
Dispensing Mifepristone can be dispensed directly to patients by a pharmacist or prescribing health professional, rather than the original requirement that a physician must dispense directly to the patient. November 2017
Gestational age Mifepristone-misoprostol may be used up to 9 weeks (63 days) from the last menstrual period, rather than the original 7 weeks (49 days). November 2017
Ultrasound Removed requirement for mandatory ultrasound before prescribing. April 2019